Artivion to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Artivion (NYSE:AORT), a cardiac and vascular surgery company, announced its participation in two upcoming investor conferences. The company will present at the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025, at 10:30 a.m. ET, with a live webcast available on their website. Additionally, management will participate in investor meetings at the 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2025, though no webcast will be available for this event.

News Market Reaction – AORT

-2.09%

-2.09% Session move

In the trading session that priced this news, AORT declined 2.09%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ATLANTA, July 30, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Canaccord Genuity 45^th Annual Growth Conference on Wednesday, August 13, 2025 at the InterContinental Boston Hotel. The Company's presentation is scheduled to begin at 10:30 a.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page.  An archived copy of the webcast will be available for 90 days on the same website. 

Artivion management will also be participating in investor meetings at the 10^th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 12, 2025. Due to the format of this event no webcast will be available.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

Contact:

Artivion	Gilmartin Group LLC
Lance A. Berry	Brian Johnston / Laine Morgan
Executive Vice President &	Phone: 332-895-3222
Chief Financial Officer	investors@artivion.com
Phone: 770-419-3355

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302517744.html

SOURCE Artivion, Inc.

FAQ

When is Artivion (AORT) presenting at the Canaccord Genuity Growth Conference?

Artivion will present on Wednesday, August 13, 2025 at 10:30 a.m. ET at the InterContinental Boston Hotel.

How can investors access Artivion's Canaccord conference presentation?

Investors can access the live webcast through Artivion's website (www.artivion.com) on the Investors page. The archived webcast will be available for 90 days.

Which investor conferences will Artivion (AORT) attend in August 2025?

Artivion will attend the Canaccord Genuity 45th Annual Growth Conference on August 13 and the 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2025.

Will there be a webcast available for Artivion's Needham conference participation?

No, there will be no webcast available for the Needham Virtual MedTech & Diagnostics Conference due to its 1x1 meeting format.